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IMPLICATIONS ANDPurpose: It is well established that exposures during childhood and adolescence affect breast
cancer risk much later in life. Recently, studies have begun to evaluate whether early life exposures
might also impact the risk of developing benign breast disease (BBD). A diagnosis of proliferative
BBD independent of other breast cancer risk factors also increases the subsequent risk of breast
cancer; therefore, understanding how to decrease the incidence of BBD may have important
implications for primary breast cancer prevention.
Methods: We reviewed several studies from prospective cohort studies that have investigated the
relationship between risk factors during childhood and adolescence, such as anthropometric and
reproductive characteristics as well as diet and other behaviors, and subsequent risk of BBD.
Results: Higher intake of vegetable oils, nuts, vitamin E, and ﬁber and lower consumption of
animal fat, red meat, and alcohol are associated with reduced risk of BBD. Childhood weight and
adolescent body mass index are inversely associated with BBD risk, whereas a greater peak height
velocity during adolescence is associated with a higher risk of BBD. There was no association
between age of menarche and risk of BBD.
Conclusion: Early life exposures and behaviors appear to impact BBD risk. The current body of
evidence further supports the importance of a life-course approach to breast cancer prevention.
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These ﬁndings support
a life-course approach to
preventing breast cancer.
Interventions during ado-
lescence could reduce the
risk for breast cancer later
in life.With more than 200,000 new cases of invasive breast carci-
noma reported each year, breast cancer is the most commonly
diagnosed malignancy among women in the United States [1].
Identifying opportunities for prevention of this disease by
actions earlier in life are warranted. It has become widely
accepted that exposures during childhood and adolescence can
“set the stage” for breast cancer development later in life [2e4].
Some of the earliest work on the epidemiology of breast cancer
established the importance of adolescent life events, such as age
of menarche, age at ﬁrst birth, childhood body fat, and adolescentbody mass index (BMI) in determining subsequent risk of breast
cancer [2,5e8]. These observations led to the suggestion that
there might be a window of biologic vulnerability between the
onset of menarche, when the breast tissue begins to proliferate
monthly, until the completion of the ﬁrst pregnancy, when breast
tissue undergoes terminal differentiation into milk-producing
cells [4]. Certainly, the vulnerability of the breast to irradiation
is inversely related to age at exposure; this observation has been
borne out not only among girls who survived the atomic bomb
explosions in Hiroshima or Nagasaki but also among female
survivors of Hodgkin’s disease who underwent chest irradiation
as part of their treatment [4]. In addition, ﬁndings from some
studies suggest that women who begin drinking or smoking at
younger ages are at increased risk for breast cancer [4,9].
The impact of early life exposures on breast cancer develop-
ment is supported by animal model data. In a series of classic
experiments, Russo and Russo demonstrated that rats with
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ated were more likely to develop breast tumors when exposed
to chemical carcinogens than rats whose mammary glands had
gone through terminal differentiation [10].
So-called benign breast disease (BBD) is a condition diag-
nosed in women beginning in the late teenage years. BBD is not
a precursor lesion to breast cancer in the sameway that a polyp is
a precursor to colon cancer. A polyp is a dysplastic lesion that if
left in situ has a high likelihood of acquiring additional mutations
that will cause it to progress to colorectal cancer. BBD is instead
a marker of a proliferative state of the breast that is a “herald” or
“early warning sign” that a cancerous process may initiate else-
where within the breast. Although many studies have shown
that a higher proportion of breast cancers will subsequently
develop in the same breast in which the BBD was diagnosed, the
diagnosis of atypical BBD lesions also confer an increased risk of
cancer in the contralateral breast [11,12].
BBD is generally classiﬁed into three types of lesions: (1) non-
proliferative (without atypia); (2) proliferative without atypia;
and (3) atypical hyperplasia [13]. The degree of risk conferred by
BBD has been quantiﬁed by grading the amount of proliferation
and atypia in the BBD lesion [14,15]. Likelihood of developing
cancer is dependent on these pathologic categorizations: relative
risks (RR) for breast cancer range from approximately 60%
increase in risk for nonproliferative BBD without atypia among
womenwith a family history positive for breast cancer, to greater
than a fourfold increased risk of breast cancer amongwomenwith
atypical hyperplasia [12]. Thus, the risk conferred byadiagnosis of
BBD is analogous to the much more recognized risk of having
a family history of breast cancer (RR of 1.5e3.0) for a mother or
sister with breast cancer [12]. Given this strong association,
understanding how to decrease the incidence of BBD may have
important implications for primary breast cancer prevention.
Study Population
Much of the evidence that has emerged on the relation
between adolescent risk factors and BBD is based on data from
several large studies: (1) the Women’s Health Initiative (WHI);
(2) the Nurses’ Health Study II (NHS); and the (3) Growing Up
Today Study (GUTS). The WHI included a series of randomized
control trials, with more than 68,000 postmenopausal women
enrolling into the WHI between 1993 and 1998 [16,17]. At base-
line, women enrolled in the WHI trials were surveyed about past
health and reproductive behaviors [17]. The NHS II cohort was
established in 1989, enrolling 116,671 women, aged 25e44, who
are sent surveys that ask about a wide range of medical and life-
style issues, every 2 years [18]. The GUTS cohort comprises the
offspring of the women in the NHS II; GUTS was initiated in 1996
and enrolled 9,037 girls, aged 9e15 [19]. GUTS has prospectively
collected comprehensive childhood and adolescent diet and
lifestyle informationwhereas the NHS II, in contrast, must rely on
adult recall of adolescent diet and behavior. Several studies,
however, have demonstrated that diet, alcohol use, and physical
activity can bemeasuredwith reasonable levels of reproducibility
and validity many years later [20e22].
Although BBD cases are initially identiﬁed in both the NHS II
and GUTS by self-report (including a question about whether the
diagnosis was “biopsy-conﬁrmed”) on biannual surveys, both
studies ask for consent from participants for study pathologists
to collect and review the biopsy specimens [22]. BBD samples
have been collected in sequential studies in the NHS II. In aninitial study of dietary factors and BBD in the NHS II, 91% of
women consented to pathology review and investigators were
able to access and review 94% of these samples [18]. In the study
of early life factors and BBD, fewer women (77%) consented;
however, among this subset, 91% of samples were available for
review [22]. A validation study conducted within the NHS II re-
ported high concordance (95%) between self-report of BBD and
pathology-conﬁrmed cases [19]. A similar process of pathologic
veriﬁcation is currently underway in GUTS. The pathology review
by NHS II pathologists also allows for the lesions to be classiﬁed
as proliferative or nonproliferative and also notes the presence or
absence of atypia, which as detailed previously, has important
implications for breast cancer risk.
Anthropometric Factors
Body mass index and weight
In the GUTS cohort, higher BMI as measured during middle
school and high school was associated with a slightly decreased
BBD risk [23]. Girls with a BMI in the upper two quintiles of BMI
had less than half the risk (OR: .46 95% CI: .26e.81) compared
with those with a BMI in the lower three quintiles [23]. This is
consistent with results from the NHS II, which found that body
fat composition measured in children between the ages 5 and 10
to be inversely related to proliferative BBD (P-BBD) risk, with the
heaviest children having the lowest risk of BBD (RR: .61, 95%
CI: .44e.86) [22]. This protective effect was apparent in later
adolescence as well: a BMI 25 at age 18 was associated with
a 33% reduction in BBD risk [22]. These results support the well-
documented relationship between higher BMI and reduced risk
of premenopausal breast cancer [2,24].
Growth velocity and height
In the GUTS cohort, Berkey et al. reported that a faster rate of
growth was associated with BBD risk; girls with peak height
velocity >8.9 cm/year were nearly twice as likely to develop BBD
relative to the girls whose peak height velocity was7.6 cm/year
[23]. Attained adult height (reported at ages 18e27), however,
was not associated with BBD in the GUTS cohort [23]. Similarly,
Baer et al. did not ﬁnd any association between height and
premenopausal P-BBD, suggesting that rate of growth rather
than attained height is the more important factor relating to
premenopausal BBD development [22]. Similarly, a study in
Denmark that linked school heath records with breast cancer
registry data reported a RR of breast cancer of 1.17 (95% CI:
1.09e1.25) for each 5-cm increase in height among peripubertal
8- to 14-year-old girls [3].
Age at Menarche and Other Reproductive Factors
In their analysis of risk factors for premenopausal P-BBD in
the NHS II, Baer et al. analyzed a range of reproductive char-
acteristics. With the exception of a slightly elevated risk seen
among women who were younger at ﬁrst birth (before age 25)
and reported only one to two pregnancies, there were no other
signiﬁcant predictors of a P-BBD diagnosis after adjusting for
other covariates [22]. In the GUTS cohort, Berkey et al. did not
ﬁnd any association between age of menarche and BBD risk
[23,25]. These ﬁndings are consistent with other studies that
also have failed to ﬁnd any relationship between early age of
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ported a differential impact of the pathologic subtype of BBD on
the relationship between age at menarche and subsequent
breast cancer risk among women in the NHS II [28]. Among
women with P-BBD and atypia, those who experienced
menarche at age 15 had a risk of .83 (95% CI: .73e.93) relative to
those who experienced menarche at age 11 [28]. Women with
P-BBD without atypia also had a lower risk of breast cancer (RR:
.93, 95% CI: .86e.99), whereas women with nonproliferative
BBD who were age 15 at menarche had a higher risk (RR: 1.16,
95% CI: 1.08e1.24) compared with women who were age 11 at
menarche [28].
Dietary Factors
Fats, meats, and dairy
In their study of adolescent diet and subsequent P-BBD risk
among the NHS II cohort, Baer et al. investigated the association
between type of fat and BBD. Those who were in the top quartile
of animal fat consumption had a 33% increased risk of P-BBD,
whereas those women who were in the highest quartile of
vegetable fat consumption had a 27% reduced risk of P-BBD [18].
The highest quartile of monounsaturated fat consumption was
associated with a relative risk of 1.52 [18]. No association with
total fat consumption was found [18].
Baer et al. also reported an elevated risk of P-BBD (RR: 1.50, 95
CI%: 1.01e2.22) amongwomenwho ate three or more portions of
any meat per day during adolescence, compared with women
who ate<1.5 portions of meat per day; speciﬁcally, redmeat was
associated with a 33% increased risk of P-BBD in women who
consumed at least two portions/day compared with womenwho
consumed less than a single serving a day [18]. There were no
signiﬁcant associations found between milk or dairy product
consumption and BBD [18].
Many of these results are consistent with ﬁndings from
analyses of adolescent diet and breast cancer risk. In an analysis
of the NHS II, Frazier et al. reported a reduced risk (RR: .58, 95%
CI: .38e.86) among those in the highest quintile of vegetable fat
consumption compared with the ﬁrst quintile [29,30]. In an
updated analysis of adolescent diet and breast cancer in the NHS
II, Linos et al. did report that an association with total fat, after
controlling for red meat, was no longer signiﬁcant [30]. Although
some studies have reported protective trends associated with
increased dairy and milk product consumption during adoles-
cence, these have generally not been signiﬁcant [29,30]. Michels
et al. have examined the impact of early childhood diet, as
recalled by the mother, on risk of breast cancer. In her analysis,
eating French fries between the ages of 3 and 5 was associated
with an increased risk (OR: 1.27, 95% CI: 1.12e1.44) , whereas
drinking milk was associated with a decreased risk (OR: .90, 95%
CI: .82e.99) [31].
Fiber, fruits/vegetables, and nuts
In the NHS II cohort, those in the fourth (highest) quartile of
adolescent ﬁber consumption had a 25% decreased risk of P-BBD
compared with those in the bottom quartile [18]. A similar risk
reduction (HR: .75, 95% CI: .59e.96) attributed to ﬁber was re-
ported by Su et al. in an updated analysis of the NHS II data [32].
Although total ﬁber intake conferred a protective effect, there
was little evidence of an association between eating ﬁber derivedfrom produce (fruits and vegetables) and P-BBD [18,32]. Eating at
least one to three apples a month, however, was associated with
almost a 40% reduction in risk (relative to eating less than one per
month) [32]. In contrast to BBD, adolescent ﬁber, fruit, or vege-
table consumption have not been associated with subsequent
breast cancer risk [29,30].
In the NHS II cohort, women who ate the most nuts (two or
more small bags or at least 1 oz. per week) had the lowest risk
(HR: .64, 95% CI: .48e.85) of BBD [32]. In an analysis of speciﬁc
types of nuts, womenwho had at least one serving of peanuts per
week had about 1/3 of the risk of P-BBD compared with women
who ate less than one serving a month [32]. Consumption of
other types of nuts also showed a similar affect but the amount
required was larger: eating two or more servings per week
compared with less than one serving a month was associated
with a hazard ratio of .62 (95% CI: .44e.88) [32].
Vitamins and micronutrients
In the analysis of adolescent diet and P-BBD risk in the NHS II
cohort, there was a signiﬁcant protective trend for vitamin E and
vitamin A [18]. Vitamin E intake during adolescence also appears
to be an important factor in relation to risk of breast cancer; in
the NHS II, women in the 5th quintile had a relative risk of .61
(95% CI: .42e.89), compared with the ﬁrst quintile [29]. There
was no association between P-BBD and any of the other vitamins
and micronutrients examined, including lycopene, retinol, caro-
tene (a and b), vitamin C, and folate [18]. Calcium and vitamin D
intake was not reported in this analysis; however, a recent
randomized control trial of calciumþD supplementation con-
ducted within the WHI (a postmenopausal population) did not
ﬁnd a lower risk of proliferative BBD among womenwhowere in
the intervention arm [33]. Because this study investigated
supplementation in an older population of women, these ﬁnd-
ings do not preclude the possibility that calcium intake during
childhood and adolescence might affect BBD. Further studies are
needed to better elucidate early life calcium and vitamin D
intake/supplementation and BBD risk.
Lifestyle Factors
Alcohol
Berkey et al. assessed the frequency, amount, and binge
drinking among females ages 16e23, and diagnosis of BBD [19].
In this analysis, more than a ﬁvefold risk of BBD was associated
with drinking 6 to 7 days per week and more than a threefold
increased risk associated with drinking 3 to 5 days per week,
relative to women who drank less than once a week or did not
drink at all [19]. No effect was seen for binge drinking. Baer et al.
also reported a slightly increased risk of premenopausal P-BBD in
women who drank between the ages of 18 and 22, although risk
was not dose-dependent [22]. Compared with nondrinkers,
women in the NHS II who drank 10 grams alcohol per day
between ages 18 and 22 had a RR of 1.25 (95% CI: 1.02e1.54),
women who drank 5 to 9.9 g/day had an RR of 1.31 (95% CI:
1.07e1.60), women who drank 1.5 to 4.9 g/day had an RR of 1.23
(95% CI: .95e1.60), and women who drank .1 to 1.4 g/day had an
RR of 1.23 (95% CI: 1.01e1.50) [22].
A recent analysis examining the relationship between several
risk factors for BBD among those with a family history of breast
cancer suggests that alcohol might be an important modiﬁer of
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associated with an increased risk of BBD in women without
a family history of either breast cancer or BBD; however, among
women with a mother, aunt, or grandmother with breast cancer,
drinking seven alcoholic beverages each week during adoles-
cence was associated with an increased risk of BBD (OR: 2.28, p¼
.01) relative to women who did not report any alcohol
consumption [25]. Among womenwith a family history of either
maternal BBD or breast cancer, those whowere in the uppermost
quartile of alcohol use for their speciﬁc age (one or more serv-
ings/week at age 16, two servings/week at age 18, three servings/
week at age 19) had an increased risk of BBD (OR: 2.27, p ¼ .03)
compared with women with a negative family history who did
not consume alcohol [25].
Lifetime alcohol consumption is one of the most well-
established lifestyle factors associated with an increased breast
cancer risk [34,35]. However, the evidence linking adolescent
alcohol intake to breast cancer later in life is mixed. Although
some studies have reported an increased risk associated with
alcohol use at younger ages, the relative contribution of adoles-
cent alcohol consumption is still unclear [4]. In the NHS II, there
was no association between alcohol use between the ages of 15
to 17 or 18 to 22 and breast cancer [36]. A recent case-control
study assessing alcohol consumption between the ages of 15
and 20 also did not ﬁnd women had an increased risk of breast
cancer diagnosed before the age of 50 [37].
Physical activity
There is little evidence that physical activity (PA) during
childhood and adolescence has a meaningful impact on BBD
development. Baer et al. detected a protective effect (RR: .65, 95%
CI: .50e.84) in women who performed “strenuous” PA 4 to 6
months a year while they were in high school; however, this
effect was not apparent in women who reported more frequent
strenuous activity during this time [22]. A recent analysis con-
ducted within NHS II explored lifetime PA, including frequency,
duration, and type, reported a relationship between increased
PA, and decreased P-BBD risk [38]. The primary exposure in this
study, however, was lifetime PA and not early life PA. Although PA
during adolescencewas incorporated in the composite PAmetric,
it is unclear to what degree adolescent PA contributed to the
protective trend, relative to and in combination with, activity
during adulthood. The beneﬁcial impact of PA during childhood
and adolescence on breast cancer risk is also uncertain; although
some studies have found that increased PA does reduce risk,
many of analyses fail to properly adjust for BMI a potential
confounder [39].
Smoking
Although the overall association linking smoking to breast
cancer risk is weak, there are some studies that suggest that
women who initiate smoking many years before their ﬁrst
pregnancy do in fact have an increased risk of breast cancer [9].
Given this evidence, it is plausible that BBD risk might be
increased in women who start smoking during adolescence. In
their study of P-BBD risk in premenopausal women, after
adjusting for several other risk factors, Baer et al. did not ﬁnd any
signiﬁcant association between smoking and BBD risk [22]. These
results are consistent with those from an analysis in the WHI, in
which the authors reported no increased risk of postmenopausal,benign proliferative epithelial disorder among women who
began smoking as teenagers [40].
Adolescent risk factors for BBD risk for the most part mimic
the effects observed for breast cancer. However, among those
factors that are modiﬁable, a reduced rate of BBD may herald
a reduced incidence of breast cancer in later life and therefore
BBD may be an important surrogate in prevention intervention
trials. Potentially modiﬁable dietary intake may include higher
intake of vegetable oils, nuts, vitamin E, and ﬁber and lower
consumption of animal fat, red meat, and alcohol. Increased
physical activity may also reduce risk. However, these ﬁndings
should be interpreted cautiously given some of the methodologic
challenges that exist, including exposure and outcome misclas-
siﬁcation, both differential (mainly from bias related to recall of
exposures from many years earlier) and nondifferential. Addi-
tionally, studies often use analysis-speciﬁc categorizations (i.e.,
quartiles based on the distribution of the exposure in a particular
cohort) or deﬁne key covariates differently (i.e., deﬁnitions of
physical activity), which can make it difﬁcult to compare results
across studies. Some studies have only identiﬁed cases of BBD
among premenopausal women. It is possible that several early
life factors might confer either a protective or harmful effect on
postmenopausal BBD; continued follow-up in these studies will
better appreciate any differences between pre- versus post-
menopausal risk. However, a life-course framework for inter-
ventions that recognizes the importance of healthy choices
during adolescence offers some promise of making some inroads
into the hardship and premature death associated with the
diagnosis of breast cancer.
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